About UsEDP is committed to developing simple, accurate and cost-effective diagnostics that detect disease early.
EDP Biotech Corporation is a privately held medical device company focused on the development and commercialization of immunodiagnostic tests for humans and animals.
EDP performs research and develops products to identify and purify proteins present in the early stages of biological changes for production of in vitro diagnostic tests whose primary target is early detection.
EDP’s first commercial product ColoPlex™, is a new biomarker assay to be used in the early detection of colorectal cancer.
EDP anticipates launching ColoPlex™ in 2018 in Europe.
Meet our team of highly qualified professionals
EDP Biotech’s private investors have supported ColoPlex™ as it moves past the research and development stage towards commercialization.
EDP Biotech Corporation is looking for qualified distributors of non-competitive IVD products for various regions internationally.